ARDX

ARDX

USD

Ardelyx Inc. Common Stock

$5.695-0.005 (-0.088%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$5.700

Haut

$5.780

Bas

$5.630

Volume

2.70M

Fondamentaux de l'Entreprise

Capitalisation Boursière

1.4B

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

3.69M

Bourse

NGM

Devise

USD

Intervalle sur 52 Semaines

Bas $3.21Actuel $5.695Haut $6.78

Actualités Connexes

Analyst Upgrades

Piper Sandler Maintains Neutral on Ardelyx, Raises Price Target to $10

Piper Sandler analyst Christopher Raymond maintains Ardelyx with a Neutral and raises the price target from $9 to $10.

Voir plus
Piper Sandler Maintains Neutral on Ardelyx, Raises Price Target to $10
GlobeNewswire

Ardelyx President and Chief Executive Officer Mike Raab to Participate in the Wedbush Rewind American Society of Nephrology 2025 Investor Conference

WALTHAM, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet

Voir plus
Ardelyx President and Chief Executive Officer Mike Raab to Participate in the Wedbush Rewind American Society of Nephrology 2025 Investor Conference
Analyst Upgrades

Citigroup Maintains Buy on Ardelyx, Raises Price Target to $11

Citigroup analyst Yigal Nochomovitz maintains Ardelyx with a Buy and raises the price target from $10 to $11.

Voir plus
Citigroup Maintains Buy on Ardelyx, Raises Price Target to $11
Analyst Upgrades

TD Cowen Maintains Buy on Ardelyx, Raises Price Target to $10

TD Cowen analyst Joseph Thome maintains Ardelyx with a Buy and raises the price target from $9 to $10.

Voir plus
TD Cowen Maintains Buy on Ardelyx, Raises Price Target to $10

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.